Internal Reference Number: FOI_7607
Date Request Received: 08/12/2023 00:00:00
Date Request Replied To: 18/12/2023 00:00:00
This response was sent via: By Email
Request Summary: Asthma
Request Category: Researcher
Question Number 1: How many patients have been treated (for any condition) in the last 4 months with: • Benralizumab • Dupilumab • Omalizumab • Reslizumab • Mepolizumab • Tezepelumab | |
Answer To Question 1: Benralizumab 0 Patients • Dupilumab 0 Patients • Omalizumab 48 Patients • Reslizumab 0 patients • Mepolizumab 0 Patients • Tezepelumab Patients | |
Question Number 2: Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age groups: • Age 6 - 11 • Age 12 - 17 • Age 18 and above | |
Answer To Question 2: • Age 6 - 11 0 Patients • Age 12 - 17 0 patients Age 18 and above - 48 Patients. | |
Question Number 3: How many patients have been treated in the last 4 months by the Respiratory Medicines Department ONLY with: • Dupilumab • Omalizumab | |
Answer To Question 3: • Dupilumab 0 Patients • Omalizumab 48 Patients | |
To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.